Quarterly Activity Report for 31 March 2021 — Appendix 4C

Imagion Biosystems today released its Appendix 4C Quarterly Cashflow report and update on Company activities for the quarter ending 31 March 2021 (Q1 FY2021).

Q1 highlights:

  • A second clinical site was established for the Phase I HER2 Breast Cancer Study
  • Initiation of research for prostate cancer imaging supported by CSIRO funds
  • Secured new premises from November 2021 enabling increased manufacturing capabilities

Read the Quarterly Activity Report for March 31, 2021